ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
ZEO Scientifix Inc (QB)

ZEO Scientifix Inc (QB) (ZEOX)

1.95
0.15
(8.33%)
Cerrado 31 Julio 3:00PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
1.95
Postura de Compra
1.57
Postura de Venta
2.43
Volume Operado de la Acción
1,035
1.95 Rango del Día 1.95
0.80 Rango de 52 semanas 2.99
Precio Anterior
1.80
Precio de Apertura
1.95
Última hora de negociación
Volumen promedio (3 m)
5,488
Volumen financiero
US$ 2,018
Precio Promedio Ponderado
1.95

ZEOX Últimas noticias

Northern Illinois Families and Businesses Experienced Record Electric Reliability in 2022

ComEd investments are preparing the grid for climate change impacts and the clean energy transition Investments in the power grid continued to pay reliability dividends for ComEd customers as...

ComEd Offering $500,000 in Grant Funding for Community-Oriented Projects Across Northern Illinois

Annual Powering Communities Grants Program provides grants of up to $10,000 each to improve infrastructure and quality of life in Illinois communities ComEd today announced that municipal and...

ComEd Awarded for Two Programs That Make Energy Efficiency Benefits More Accessible to Families and Businesses

Multi-Family Energy Savings and Energy Efficiency Service Provider Incubator programs recognized by Midwest Energy Efficiency Alliance The Midwest Energy Efficiency Alliance (MEEA) has...

Exelon announces Jane S. Park as senior vice president of Federal Governmental and Regulatory Affairs, and Public Policy

Park’s experience in regulatory energy policy, clean energy initiatives, customer operations and strategic technology investments will help Exelon advocate for sound energy policies to power a...

New ComEd Substation Brings Science to Life at Argonne National Laboratory

To provide the reliable energy required to power groundbreaking discoveries in energy, transportation and medical treatments, ComEd has completed a new substation at the U.S. Department of...

Exelon Named to the Dow Jones Sustainability Index for 17th Consecutive Year

Exelon (EXC) was named to the Dow Jones Sustainability North America Index (DJSI) for the 17th consecutive year, once again earning recognition for its carbon reduction efforts, investments in...

ComEd Multi-Year Plans Advance Region’s Economic, Climate and Equity Goals

Outline grid work needed to maintain record-breaking reliability Support expansion of renewables and beneficial electrification Prioritize under-resourced communities, spur local job creation...

What People Are Saying About ComEd’s Multi-Year Plans That Advance Region’s Economic, Climate and Equity Goals

A wide variety of municipal, business, community and labor leaders from across northern Illinois and beyond today released statements about ComEd’s multi-year grid and rate plans that advance the...

New Study Projects Clean Energy Transition Could Create More than 150,000 New Jobs in Illinois by 2050

First-of-its-Kind Study of Illinois Energy Transformation Identifies Job Training Needs Also Projects Clean Energy Transition Could Create More Than 40,000 New Jobs in Illinois by 2030 National...

ComEd Earns National Recognition for Outstanding Emergency Response Efforts

Awards recognize ComEd’s local recovery, mutual support efforts to southern electric companies following Hurricane Ian in 2022 The Edison Electric Institute (EEI), a national association that...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.15-7.142857142862.12.151.822601.93351327CS
40.211.42857142861.752.831.6555602.235007CS
120.8577.27272727271.12.830.854881.77721435CS
26-1.04-34.78260869572.992.990.844671.73940307CS
52-1.04-34.78260869572.992.990.844671.73940307CS
156-1.04-34.78260869572.992.990.844671.73940307CS
260-1.04-34.78260869572.992.990.844671.73940307CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CLCSCell Source Inc (CE)
US$ 0.35
(43,650.00%)
18.69k
RCCMFGETT Gold Inc
 0.023
(11,400.00%)
500
ATHXQAthersys Inc New (CE)
US$ 0.0001
(9,900.00%)
1.81k
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0.0001
(9,900.00%)
123.3M
HBRMHerborium Group Inc (PK)
US$ 0.0001
(9,900.00%)
870.51k
NOKPFNok Airlines Public Company Ltd (CE)
US$ 0.000001
(-99.99%)
55k
OIBZQOi SA (CE)
US$ 0.0002
(-99.88%)
20.4k
FBECFBEC Worldwide Inc (CE)
US$ 0.000001
(-99.50%)
350.01k
NTURNatural Blue Resources Inc (CE)
US$ 0.000001
(-99.45%)
1.7k
BGMDBG Medicine Inc (CE)
US$ 0.000001
(-99.23%)
4.8k
SIRCSolar Integrated Roofing Corporation (PK)
US$ 0.0001
(9,900.00%)
123.3M
KGKGKona Gold Beverage Inc (PK)
US$ 0.0006
(-14.29%)
116.34M
HMBLHUMBL Inc (PK)
US$ 0.0002
(-23.08%)
115.77M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0039
(-3.94%)
105.42M
NTRRNeutra Corporation (PK)
US$ 0.0002
(-33.33%)
89.26M

ZEOX Discussion

Ver más
Renee Renee 5 meses hace
OCEL: effective March 5,2024 Organicell Regenerative Medicine Inc, OCEL, will change to Zeo ScientifiX Inc, ZEOX:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
backtoreality backtoreality 5 meses hace
There aren't many shares after the RS so it'll move.
👍️0
BLUEVOODU BLUEVOODU 5 meses hace
Thank you - I think the thing that bothers me most over the last year is the lack of news.

After all the changes in leadership, the money they sunk into Ocel … etc… the lack of news is interesting.

Maybe something is brewing again. Lol Let’s go $20. We are only $16.80 away
👍️0
backtoreality backtoreality 5 meses hace
Wishing you the best Blue!
👍️0
BLUEVOODU BLUEVOODU 5 meses hace
Interesting action as of late. Nice increases.

I’m trying to find news as to what’s happening and cannot. However, we are hovering close to $3.50 a share now.

Let’s go! And let there be great news.
👍️0
backtoreality backtoreality 8 meses hace
OTC is a crap shoot. I have a few stocks where management is very quite. The new Regulations may have company's worried about what they say and do.

Ocel got flagged for something like that as well. Best of luck to you. Hopefully the OTC makes a turn around and volume will pick up. But as far as I'm concerned everything is a shit show as well as the stock market.

Hopefully the country gets it right this time in 2024 or I'll be moving to Mexico and praying they don't cut social security .

Good luck. If they get FDA approval to move forward things can change fast. I met a guy on a plane. 62, a healthy firefighter that suddenly got sick. He needs a heart transplant and all they tell him it has something to do with covid....
👍️0
BLUEVOODU BLUEVOODU 8 meses hace
I still have a decent amount of shares. It would take a significant run to get me back to even. Made money in covid run too.

I’m not holding my breath right now. I really don’t like R/S’s. It tends to be the kiss of death to value 95% of the time.

They’re not putting out any news. No news about internal structure… or product. I was hopeful with the management changes.
👍️0
backtoreality backtoreality 8 meses hace
Fortunately I made some $ when they had their covid run.
👍️0
bude bude 8 meses hace
Yes, has rs’d twice pass 3 years 1st split my shares down to 12. Last split down to one.
👍️0
backtoreality backtoreality 8 meses hace
Do you have many shares left post split? I dumped most. Was it 500 to 1 split?

They stated it would crush retail. If the drug gets FDA approval it should take off.
👍️0
BLUEVOODU BLUEVOODU 8 meses hace
Still around! It’s been very busy.

Saw the r/s was approved.
👍️0
backtoreality backtoreality 8 meses hace
You still around
👍️0
Renee Renee 8 meses hace
OCEL: effective Nov. 28,2023 a one for 200 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
backtoreality backtoreality 9 meses hace
They have been Very transparent that this RSb1 for 500bshares will happen
👍️0
BLUEVOODU BLUEVOODU 9 meses hace
Did they announce that was happening. Or did it get approved? I lost track for a bit.

They’re definitely dipping today
👍️0
bransteff bransteff 10 meses hace
Yup terrible for retail
👍️0
backtoreality backtoreality 10 meses hace
1 share for every 500. Bye bye retail
👍️0
bransteff bransteff 11 meses hace
Let's gooo
👍️0
backtoreality backtoreality 12 meses hace
I dumped half my holding here as soon as I heard RS. And my luck they'll get a big cash infusion from a gooverment grant.
👍️0
ErnieBilco ErnieBilco 12 meses hace
Long odds on it uplisting, not many .01 stocks make it to the big boards.

BUT, insiders did buy 2.77 million shares in the past month or so so something is about to happen. Most of the buys were sub penny.

Watching from the sidelines unless my bait get grabbed.
👍️0
backtoreality backtoreality 12 meses hace
Well if they were going to follow it with an immediate uplist it could work but in most cases the stock will get shorted to hell and back.
👍️0
ErnieBilco ErnieBilco 12 meses hace
The ratio is up to 300 to 1 - that's not just a lil share structure adjustment - that is crap you would see the gooberment do.
👍️0
backtoreality backtoreality 12 meses hace
Well anytime there's a mention of reverse split the stock price tanks. So far she's holding up.
👍️0
backtoreality backtoreality 12 meses hace
Well there it is. Figured it would happen.
👍️0
backtoreality backtoreality 1 año hace
So the drug looks good safety wise. P 2 is on deck, but will require Funding. At 2 pennies a share selling shares won't cut it. They need grants or maybe even some type of partnership.
👍️0
backtoreality backtoreality 1 año hace
Perhaps the company is getting smart and will stop trying to raise funds when the momo isn't there?

They are recruiting for a trial at this time.Not sure why you said they're not in trials? Wish we could get an update but the crooked OTC slapped them with some BS and they maybe playing there hand close to the chest
👍️0
fourcloze fourcloze 1 año hace
Yup, well, there ya go. Down 16% today. If this thing did hit and actually had real trials that worked and FDA approved, I'd be set I think. Good luck.

-OUT-
👍️0
backtoreality backtoreality 1 año hace
I was referring to in the "short term" not my long term outlook.

I've been here since they first announced having a potential covid drug 3 ish years ago. I buy n sell their shares as I see fit. If this trend keeps going up I will be a very happy investor.

GLTU looking at the chart it appears the trend is going up and hope it sustains higher highs and lows. Good timing on your part.
👍️0
fourcloze fourcloze 1 año hace
lol, thought you were 'suckered' in last time?
👍️0
backtoreality backtoreality 1 año hace
Folks sitting on the fence may want to start accumulating .
👍️0
backtoreality backtoreality 1 año hace
I got suckered in to buying the last time it popped only to have it drop back down under a penny.
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Also looks like the old director has resigned… the one they accused of mishandling business.

Turn around coming? Wish I had bought more lower.
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Looks like more insider investment over the last couple days
👍️0
bransteff bransteff 1 año hace
Looking good
👍️0
backtoreality backtoreality 1 año hace
Yup, don't know what it will amount too.
👍️0
BLUEVOODU BLUEVOODU 1 año hace
Pretty Weighty... Did anyone see this?
http://archive.fast-edgar.com/20230609/APZ2L22CN222M2ZH222B22ZYGM3Q422SZ252/
👍️0
backtoreality backtoreality 1 año hace
Ba s tards taking it back. Faked me into buying rinse n repeat
👍️0
backtoreality backtoreality 1 año hace
It sure seems like we are basing at a new level.
👍️0
backtoreality backtoreality 1 año hace
That's because of them getting that slap on the wrist by the Regulators maybe. Also as long as they are recruiting there really is nothing to report. Recruiting is expected to last till the end of this year
👍️0
BLUEVOODU BLUEVOODU 1 año hace
It’s interesting as there is absolutely no news. Nothing more from new management. Etc.
👍️0
backtoreality backtoreality 1 año hace
I'd keep cash on hand and keep an eye out for news so you can buy asap if news hits. I don't think there are many eyes on this.
👍️0
BLUEVOODU BLUEVOODU 1 año hace
It’s tempting to buy more. But there’s absolutely no news. Everything went silent
👍️0
backtoreality backtoreality 1 año hace
Bottom in?
👍️0
backtoreality backtoreality 1 año hace
I'm seeing more energy in otc plays.

Ocel has backing to finance this P1 trial for a unmet issue copd. Especially when covid really does damage to those with these pre conditions.

Price is right for a Risk Reward play
👍️0
backtoreality backtoreality 1 año hace
Let's see where we are end of week..
👍️0
backtoreality backtoreality 1 año hace
Is the bottom in?
👍️0
backtoreality backtoreality 1 año hace
Is the Bottom in. TIME WILL TELL
👍️0
backtoreality backtoreality 1 año hace
Why invest here on speculation of what may transpire with the copd trial. They will dilute the share price so low that if Zofin ends up showing promise an investor will have time to load up sub pennyish.
👍️0
backtoreality backtoreality 1 año hace
Why invest here on speculation of what may transpire with the copd trial. They will dilute the share price so low that if Zofin ends up showing promise an investor will have time to load up sub pennyish.
👍️0
backtoreality backtoreality 1 año hace
So who is selling? The company or the past employees who gifted themselves millions of shares before being let go?
👍️0